These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 36409061)

  • 1. Clinical outcomes and cognitive impairments between progressive supranuclear palsy and multiple system atrophy.
    Jia P; Zhang J; Han J; Ji Y
    Brain Behav; 2022 Dec; 12(12):e2827. PubMed ID: 36409061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE) performance in progressive supranuclear palsy and multiple system atrophy.
    Fiorenzato E; Weis L; Falup-Pecurariu C; Diaconu S; Siri C; Reali E; Pezzoli G; Bisiacchi P; Antonini A; Biundo R
    J Neural Transm (Vienna); 2016 Dec; 123(12):1435-1442. PubMed ID: 27334897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics and progression of cognitive deficits in progressive supranuclear palsy vs. multiple system atrophy and Parkinson's disease.
    Fiorenzato E; Antonini A; Camparini V; Weis L; Semenza C; Biundo R
    J Neural Transm (Vienna); 2019 Nov; 126(11):1437-1445. PubMed ID: 31432258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early clinical features of patients with progressive supranuclear palsy with predominant cerebellar ataxia.
    Kanazawa M; Tada M; Onodera O; Takahashi H; Nishizawa M; Shimohata T
    Parkinsonism Relat Disord; 2013 Dec; 19(12):1149-51. PubMed ID: 23916652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative cognitive and neuropsychiatric profiles between Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
    Santangelo G; Cuoco S; Pellecchia MT; Erro R; Barone P; Picillo M
    J Neurol; 2018 Nov; 265(11):2602-2613. PubMed ID: 30178175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Finger tapping analysis in patients with Parkinson's disease and atypical parkinsonism.
    Djurić-Jovičić M; Petrović I; Ječmenica-Lukić M; Radovanović S; Dragašević-Mišković N; Belić M; Miler-Jerković V; Popović MB; Kostić VS
    J Clin Neurosci; 2016 Aug; 30():49-55. PubMed ID: 27343040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary Dysfunction in Progressive Supranuclear Palsy Compared with Other Parkinsonian Disorders.
    Yamamoto T; Tateno F; Sakakibara R; Furukawa S; Asahina M; Uchiyama T; Hirano S; Yamanaka Y; Fuse M; Koga Y; Yanagisawa M; Kuwabara S
    PLoS One; 2016; 11(2):e0149278. PubMed ID: 26886104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurogenic bladder in progressive supranuclear palsy: A comparison with Parkinson's disease and multiple system atrophy.
    Kim KJ; Jeong SJ; Kim JM
    Neurourol Urodyn; 2018 Jun; 37(5):1724-1730. PubMed ID: 29356135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional brain volumes distinguish PSP, MSA-P, and PD: MRI-based clinico-radiological correlations.
    Paviour DC; Price SL; Jahanshahi M; Lees AJ; Fox NC
    Mov Disord; 2006 Jul; 21(7):989-96. PubMed ID: 16602104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical correlates of fear of falling in progressive supranuclear palsy and multiple system atrophy.
    Martínez-Villota VA; Terroba-Chambi C; Castillo-Torres SA; Rossi M; Merello M
    Eur J Neurol; 2023 Aug; 30(8):2261-2266. PubMed ID: 37183570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffusion-weighted magnetic resonance imaging differentiates Parkinsonian variant of multiple-system atrophy from progressive supranuclear palsy.
    Paviour DC; Thornton JS; Lees AJ; Jäger HR
    Mov Disord; 2007 Jan; 22(1):68-74. PubMed ID: 17089396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Speech disorders reflect differing pathophysiology in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy.
    Rusz J; Bonnet C; Klempíř J; Tykalová T; Baborová E; Novotný M; Rulseh A; Růžička E
    J Neurol; 2015; 262(4):992-1001. PubMed ID: 25683763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of autonomic dysfunction in patients with Parkinson's Disease, progressive supranuclear palsy, and multiple system atrophy.
    Malkiewicz JJ; Siuda J
    Neurol Neurochir Pol; 2024; 58(2):193-202. PubMed ID: 38148738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of survival in progressive supranuclear palsy and multiple system atrophy: a systematic review and meta-analysis.
    Glasmacher SA; Leigh PN; Saha RA
    J Neurol Neurosurg Psychiatry; 2017 May; 88(5):402-411. PubMed ID: 28250027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Higher prevalence of idiopathic normal pressure hydrocephalus-like MRI features in progressive supranuclear palsy: An imaging reminder of atypical parkinsonism.
    Fu MH; Huang CC; Wu KLH; Chen YF; Kung YC; Lee CC; Liu JS; Lan MY; Chang YY
    Brain Behav; 2023 Feb; 13(2):e2884. PubMed ID: 36635882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcomes of progressive supranuclear palsy and multiple system atrophy.
    O'Sullivan SS; Massey LA; Williams DR; Silveira-Moriyama L; Kempster PA; Holton JL; Revesz T; Lees AJ
    Brain; 2008 May; 131(Pt 5):1362-72. PubMed ID: 18385183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lower urinary tract dysfunction in Parkinsonian syndromes.
    Vichayanrat E; Hentzen C; Batla A; Simeoni S; Iodice V; Panicker JN
    Neurol Sci; 2021 Oct; 42(10):4045-4054. PubMed ID: 34318363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frontal Atrophy and Executive Dysfunction Relate to Complex Numbers Impairment in Progressive Supranuclear Palsy.
    Howard E; Ballinger S; Kinney NG; Balgenorth Y; Ehrhardt A; Phillips JS; Irwin DJ; Grossman M; Cousins KAQ
    J Alzheimers Dis; 2022; 88(4):1553-1566. PubMed ID: 35811515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrophysiological and clinical assessment of dysautonomia in multiple system atrophy (MSA) and progressive supranuclear palsy (PSP): a comparative study.
    Nojszewska M; Potulska-Chromik A; Jamrozik Z; Janik P; Zakrzewska-Pniewska B
    Neurol Neurochir Pol; 2019; 53(1):26-33. PubMed ID: 30620042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of pain in atypical parkinsonism: a systematic review and meta-analysis.
    Rana AQ; Qureshi AR; Siddiqui O; Sarfraz Z; Rana R; Shtilbans A
    J Neurol; 2019 Sep; 266(9):2093-2102. PubMed ID: 30238268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.